TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06909578: Microvascular Obstruction Diagnosis Using the CoFI™ System Assessment - II

Sponsor: CorFlow Therapeutics AG · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 200 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$10,624,000

Rescue Site Savings

+$7,005,200

Unlock Full NCT06909578 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06909578 Rescue Dossier →